Cargando…
Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impac...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143928/ https://www.ncbi.nlm.nih.gov/pubmed/32143409 http://dx.doi.org/10.3390/medicina56030110 |
_version_ | 1783519729460183040 |
---|---|
author | Imamura, Teruhiko |
author_facet | Imamura, Teruhiko |
author_sort | Imamura, Teruhiko |
collection | PubMed |
description | Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impact on the responses to cardiac resynchronization therapy. The prognostic impact of cardiac resynchronization therapy on cardiac death including heart transplantation and durable ventricular assist device implantation is another concern. |
format | Online Article Text |
id | pubmed-7143928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71439282020-04-13 Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy Imamura, Teruhiko Medicina (Kaunas) Letter Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impact on the responses to cardiac resynchronization therapy. The prognostic impact of cardiac resynchronization therapy on cardiac death including heart transplantation and durable ventricular assist device implantation is another concern. MDPI 2020-03-04 /pmc/articles/PMC7143928/ /pubmed/32143409 http://dx.doi.org/10.3390/medicina56030110 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Letter Imamura, Teruhiko Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title | Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title_full | Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title_fullStr | Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title_full_unstemmed | Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title_short | Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy |
title_sort | ischemic etiology and clinical outcomes following cardiac resynchronization therapy |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143928/ https://www.ncbi.nlm.nih.gov/pubmed/32143409 http://dx.doi.org/10.3390/medicina56030110 |
work_keys_str_mv | AT imamurateruhiko ischemicetiologyandclinicaloutcomesfollowingcardiacresynchronizationtherapy |